PUBLISHER: IMARC | PRODUCT CODE: 1298837
PUBLISHER: IMARC | PRODUCT CODE: 1298837
Gastrointestinal OTC Drugs Market by Drug Class, Indication (Gastroesophageal Reflux Disease or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User, and Region 2023-2028
The global gastrointestinal OTC drugs market size reached US$ 40 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 52.4 Billion by 2028, exhibiting a growth rate (CAGR) of 4.90% during 2023-2028. The rising prevalence of gastrointestinal disorders, increasing awareness among the masses regarding digestive health, and the recent development of advanced formulations represent some of the key factors driving the market.
Gastrointestinal over-the-counter (OTC) drugs refer to non-prescription medications that alleviate gastrointestinal symptoms and promote overall digestive wellness. It includes laxatives, antacids, H2 blockers, proton pump inhibitors (PPIs), anti-emetics, bowel anti-inflammatory, and anti-diarrheal medications. Gastrointestinal OTC drugs are widely used to treat indigestion, constipation, heartburn, diarrhea, motion sickness, acid reflux, nausea, irritable bowel syndrome (IBS), and abdominal pain. It is a cost-effective, convenient, and easily accessible product that provides immediate relief, enhances patient comfort, and allows self-management. Gastrointestinal OTC drugs also aid in improving gut health, restoring beneficial bacteria, preventing future complications, and minimizing the severity of various symptoms, such as pain, bloating, abdominal discomfort, and vomiting.
Gastrointestinal OTC Drugs Market Trends:
The rising prevalence of gastrointestinal disorders due to sedentary lifestyles and unhealthy eating habits is one of the key factors providing a thrust to the market growth. Gastrointestinal OTC drugs are widely used to treat infections, dyspepsia, acute diarrhea, heartburn, gastroesophageal reflux disease (GERD), constipation, bloating, and morning sickness. Furthermore, the increasing product applications to improve digestion, promote gut health, and ensure proper breakdown and absorption of nutrients, owing to the growing awareness among the masses regarding digestive health, is providing an impetus to the market growth. In line with this, the emerging trends of self-care and consumer empowerment to manage well-being and prevent future health complications are acting as another growth-inducing factor. Additionally, the recent development of advanced formulations, such as effervescent tablets, liquids, suspensions, film strips, and chewable products, which enhances the effectiveness of the drugs, increases absorption, and reduces the frequency of dosing, is positively influencing the market growth. Besides this, the introduction of convenient and travel-friendly packaging, such as blister packs, resealable pouches, and single-dose packets, is propelling the market growth. Apart from this, the rising consumer preference for non-invasive treatments is facilitating product demand to manage common digestive issues and provide immediate relief. Moreover, aggressive promotional and branding campaigns by several manufacturers through television (TV) commercials, social media, influencer marketing, and celebrity endorsement is strengthening the market growth. Other factors, including the rising geriatric populations, increasing expenditure capacities of consumers, and easy availability of products across e-commerce platforms, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global gastrointestinal OTC drugs market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on drug class, indication, and end user.
Drug Class Insights:
Laxatives
Gastrointestinal Cancer Treatments
Gastric Acid Reducers
Anti-Diarrheal
Proton Pump Inhibitors
H2 Inhibitors
Gastric Acid Neutralizers
Bowel Anti-Inflammatory
Anti-Emetics
The report has provided a detailed breakup and analysis of the gastrointestinal OTC drugs market based on the drug class. This includes laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti-diarrheal, proton pump inhibitors, H2 inhibitors, gastric acid neutralizers, bowel anti-inflammatory, and anti-emetics.
Indication Insights:
Gastroesophageal Reflux Disease (GERD) or Heartburn
Constipation
Diarrhea
Motion Sickness
Others
A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the indication has also been provided in the report. This includes gastroesophageal reflux disease (GERD) or heartburn, constipation, diarrhea, motion sickness, and others.
End User Insights:
Hospitals
Clinics
Others
A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the end user has also been provided in the report. This includes hospitals, clinics, and others.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for gastrointestinal OTC drugs. Some of the factors driving the North America gastrointestinal OTC drugs market included the rising prevalence of gastrointestinal disorders, increasing awareness among the masses, and various product innovations.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global gastrointestinal OTC drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim GmbH, Johnson & Johnson, Prestige Consumer Healthcare Inc., Purdue Pharma L.P, Sanofi, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global gastrointestinal OTC drugs market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global gastrointestinal OTC drugs market?
- What is the impact of each driver, restraint, and opportunity on the global gastrointestinal OTC drugs market?
- What are the key regional markets?
- Which countries represent the most attractive gastrointestinal OTC drugs market?
- What is the breakup of the market based on the drug class?
- Which is the most attractive drug class in the gastrointestinal OTC drugs market?
- What is the breakup of the market based on the indication?
- Which is the most attractive indication in the gastrointestinal OTC drugs market?
- What is the breakup of the market based on end user?
- Which is the most attractive end user in the gastrointestinal OTC drugs market?
- What is the competitive structure of the global gastrointestinal OTC drugs market?
- Who are the key players/companies in the global gastrointestinal OTC drugs market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Gastrointestinal OTC Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Class
- 6.1 Laxatives
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Gastrointestinal Cancer Treatments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Gastric Acid Reducers
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Anti-Diarrheal
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Proton Pump Inhibitors
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 H2 Inhibitors
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Gastric Acid Neutralizers
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Bowel Anti-Inflammatory
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
- 6.9 Anti-Emetics
- 6.9.1 Market Trends
- 6.9.2 Market Forecast
7 Market Breakup by Indication
- 7.1 Gastroesophageal Reflux Disease (GERD) or Heartburn
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Constipation
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Diarrhea
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Motion Sickness
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Boehringer Ingelheim GmbH
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 SWOT Analysis
- 14.3.2 Johnson & Johnson
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Prestige Consumer Healthcare Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Purdue Pharma L.P
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Sanofi
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Zydus Lifesciences Limited
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.1 Boehringer Ingelheim GmbH
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Gastrointestinal OTC Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017-2022
- Figure 3: Global: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 4: Global: Gastrointestinal OTC Drugs Market: Breakup by Drug Class (in %), 2022
- Figure 5: Global: Gastrointestinal OTC Drugs Market: Breakup by Indication (in %), 2022
- Figure 6: Global: Gastrointestinal OTC Drugs Market: Breakup by End User (in %), 2022
- Figure 7: Global: Gastrointestinal OTC Drugs Market: Breakup by Region (in %), 2022
- Figure 8: Global: Gastrointestinal OTC Drugs (Laxatives) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Gastrointestinal OTC Drugs (Laxatives) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Gastrointestinal OTC Drugs (Constipation) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Gastrointestinal OTC Drugs (Constipation) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Gastrointestinal OTC Drugs (Diarrhea) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Gastrointestinal OTC Drugs (Diarrhea) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Global: Gastrointestinal OTC Drugs (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Global: Gastrointestinal OTC Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Global: Gastrointestinal OTC Drugs (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Global: Gastrointestinal OTC Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Global: Gastrointestinal OTC Drugs (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Global: Gastrointestinal OTC Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Global: Gastrointestinal OTC Drugs (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Global: Gastrointestinal OTC Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: North America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: North America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: United States: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: United States: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Canada: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Canada: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Asia-Pacific: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Asia-Pacific: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: China: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: China: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Japan: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Japan: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: India: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: India: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: South Korea: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: South Korea: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Australia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Australia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Indonesia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Indonesia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Europe: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Europe: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Germany: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Germany: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: France: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: France: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: United Kingdom: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: United Kingdom: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Italy: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Italy: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Spain: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Spain: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Russia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Russia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Latin America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 79: Latin America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 80: Brazil: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 81: Brazil: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 82: Mexico: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 83: Mexico: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 84: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 85: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 86: Middle East and Africa: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
- Figure 87: Middle East and Africa: Gastrointestinal OTC Drugs Market: Breakup by Country (in %), 2022
- Figure 88: Middle East and Africa: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 89: Global: Gastrointestinal OTC Drugs Industry: Drivers, Restraints, and Opportunities
- Figure 90: Global: Gastrointestinal OTC Drugs Industry: Value Chain Analysis
- Figure 91: Global: Gastrointestinal OTC Drugs Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Gastrointestinal OTC Drugs Market: Key Industry Highlights, 2022 & 2028
- Table 2: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
- Table 3: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Indication (in Million US$), 2023-2028
- Table 4: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 5: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Gastrointestinal OTC Drugs Market: Competitive Structure
- Table 7: Global: Gastrointestinal OTC Drugs Market: Key Players
